AnaptysBio
ANAB
ANAB
119 hedge funds and large institutions have $659M invested in AnaptysBio in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 44 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.61% more ownership
Funds ownership: 114.2% → 115.81% (+1.6%)
7% more call options, than puts
Call options by funds: $1.28M | Put options by funds: $1.2M
30% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 44
Holders
119
Holding in Top 10
3
Calls
$1.28M
Puts
$1.2M
Top Buyers
| 1 | +$24.1M | |
| 2 | +$14.8M | |
| 3 | +$9.56M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$7.59M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$5.48M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$10.5M | |
| 3 | -$6.91M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.67M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$2.67M |